An interventional study of Diagnostic Interview for Genetic Studies and Family Informant Schedule and Criteria in Alcoholism, sponsored by CHU de Reims. Terminated at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-07-25.
Sponsored by CHU de Reims · Not applicable and Interventional
The purpose of this study is to specify the cognitive and genetic pattern associated with alcohol dependence. Results will help identifying more precisely vulnerability factors associated with this disorder.
Alcohol dependence involves both environmental and genetic vulnerability factors. Although it has a rather high degree of heritability (estimates range between 40% and 60%), vulnerability to alcohol dependence is broadly recognised as a complex polygenic phenotype. To clarify the risk factors involved in alcohol dependence, attempts have been made to identify endophenotypes in alcohol dependent patients and their relatives. Endophenotypes are defined as heritable traits associated with an increased risk for developing a disorder; they must be found in probands and their unaffected relatives at a higher rate than in the general population and must be associated with a specific genetic pattern. In the present study the investigators investigate the cognitive performance of alcohol dependent patients in comparison with a group of adult non-alcoholic offspring of alcohol-dependent patients and a group of participants without family history of alcohol dependence. The investigators also explore the relation between familial density of alcoholism and cognitive performance, particularly mental flexibility and inhibition. Genetic analysis will also be conducted to investigate the relationship between cognitive performance and genetic patterns (single nucleotide polymorphisms).
1,634 studies on the registry are indexed under Alcoholism; 329 are open to participants now.
This study's enrollment of 261 is above the median of 88 across 1,395 interventional studies indexed under Alcoholism.
Browse Alcoholism studies →CHU de Reims is the lead sponsor of 275 studies on the registry; 49 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Alcohol-dependent patients :
First-degree relatives of alcohol-dependent probands :
Healthy Controls :
Exclusion Criteria:
Alcohol-dependent patients
First-degree relatives of alcohol-dependent probands :
Healthy Controls :
Behavioral: Diagnostic Interview for Genetic Studies · Behavioral: Family Informant Schedule and Criteria · Behavioral: Temperament and Character Inventory · Behavioral: Barratt Impulsiveness Scale · Behavioral: Wisconsin Card Sorting Test · Genetic: blood sample withdrawn
Behavioral: Diagnostic Interview for Genetic Studies · Behavioral: Family Informant Schedule and Criteria · Behavioral: Temperament and Character Inventory · Behavioral: Barratt Impulsiveness Scale · Behavioral: Wisconsin Card Sorting Test · Genetic: blood sample withdrawn
Behavioral: Diagnostic Interview for Genetic Studies · Behavioral: Family Informant Schedule and Criteria · Behavioral: Temperament and Character Inventory · Behavioral: Barratt Impulsiveness Scale · Behavioral: Wisconsin Card Sorting Test · Genetic: blood sample withdrawn
questionnaire
comparison of questionnaires score for the 3 groups
Time frame: Day 0
genetic polymorphism
Time frame: Day 0
This study is terminated, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.